23 May 2013
Keywords: mayne, loses, australian, federal, epirubicin, claim, group
Article | 15 August 2005
Mayne Group, an Australian specialty drugmaker and diganostics firm, says that the Federal Court of Australia has ruled that its ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
15 August 2005
© 2013 thepharmaletter.com